|
| 37776074 | Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life (An extension to the MATE randomised controlled trial). | Acta Ophthalmol | 2024 |
| 36207506 | Practical implementation of a q4-q16 aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: Updated guidance from a UK expert panel. | Eye (Lond) | 2023 |
| 37081576 | The MATE trial: a multicentre, mixed-methodology, pilot, randomised controlled trial in neovascular age-related macular degeneration. | Pilot Feasibility Stud | 2023 |
| 36729561 | UNITED KINGDOM DATABASE STUDY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX) FOR MACULAR EDEMA RELATED TO RETINAL VEIN OCCLUSION. | Retina | 2023 |
| 35314774 | The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice. | Eye (Lond) | 2022 |
| 33420953 | Statistical Modelling of the Visual Impact of Subretinal Fluid and Associated Features. | Ophthalmol Ther | 2021 |
| 33743165 | Presumed Sertraline-Associated Maculopathy: A Case Series. | Ophthalmol Ther | 2021 |
| 33840064 | Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert Opinion. | Ophthalmol Ther | 2021 |
| 32492069 | Effectiveness and safety of ranibizumab 0.5 mg in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS study. | PLoS One | 2020 |
| 31907843 | A Review of Macular Atrophy of the Retinal Pigment Epithelium in Patients with Neovascular Age-Related Macular Degeneration: What is the Link? Part II. | Ophthalmol Ther | 2020 |
| 31900438 | Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration. | Eye (Lond) | 2020 |
| 32546938 | Providing a Safe and Effective Intravitreal Treatment Service: Strategies for Service Delivery. | Clin Ophthalmol | 2020 |
| 32144084 | Progression from Early/Intermediate to Advanced Forms of Age-Related Macular Degeneration in a Large UK Cohort: Rates and Risk Factors. | Ophthalmol Retina | 2020 |
| 30911999 | Macular Atrophy of the Retinal Pigment Epithelium in Patients with Neovascular Age-Related Macular Degeneration: What is the Link? Part I: A Review of Disease Characterization and Morphological Associations. | Ophthalmol Ther | 2019 |
| 31762771 | Unique Case of Bilateral Exudative Retinal Detachment following Creatine Supplementation in a Patient with Autosomal Dominant Bestrophinopathy. | Case Rep Ophthalmol | 2019 |
| 31416764 | Direct Ophthalmic Healthcare Resource Use among Patients with Geographic Atrophy in a Large Cohort from the United Kingdom. | Ophthalmol Retina | 2019 |
| 31602674 | Treatment decisions of UK hospital optometrists and ophthalmologists in patients with nAMD: a vignette study. | Ophthalmic Physiol Opt | 2019 |
| 31309417 | Clinical Effectiveness of Intravitreal Fluocinolone Acetonide (FAc) (ILUVIENâ¿¢) in Patients with Diabetic Macular Oedema (DMO) Refractory to Prior Therapy: The Manchester Experience. | Ophthalmol Ther | 2019 |
| 30926932 | Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service. | Eye (Lond) | 2019 |
| 29338850 | Reply. | Am J Ophthalmol | 2018 |
| 30237693 | Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group. | Clin Ophthalmol | 2018 |
| 29366564 | Characterizing Disease Burden and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration. | Ophthalmology | 2018 |
| 29101008 | Use of a Neural Net to Model the Impact of Optical Coherence Tomography Abnormalities on Vision in Age-related Macular Degeneration. | Am J Ophthalmol | 2018 |
| 27965262 | The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema. | Br J Ophthalmol | 2017 |
| 28487377 | The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema. | Br J Ophthalmol | 2017 |
| 29184385 | Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update. | Clin Ophthalmol | 2017 |
| 28572062 | The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy. | Am J Ophthalmol | 2017 |
| 26578446 | First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration. | Ophthalmology | 2016 |
| 26453639 | Ranibizumab 0.5â¿¿mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study. | Br J Ophthalmol | 2016 |
| 25892016 | Routine versus As-Needed Bevacizumab with 12-Weekly Assessment Intervals for Neovascular Age-Related Macular Degeneration: 92-Week Results of the GMAN Trial. | Ophthalmology | 2015 |
| 26446737 | Defining response to anti-VEGF therapies in neovascular AMD. | Eye (Lond) | 2015 |
| 26156564 | Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel. | Eye (Lond) | 2015 |
| 23884391 | Repeatability of visual function measures in age-related macular degeneration. | Graefes Arch Clin Exp Ophthalmol | 2014 |
| 25104747 | Reply to 'vitreoretinal surgery for inadvertent intralenticular Ozurdex implant'. | Eye (Lond) | 2014 |
| 24556884 | Accidental insertion of dexamethasone implant into the crystalline lens--12 months follow-up. | Eye (Lond) | 2014 |
| 24667012 | Comparison of mathematical morphological descriptors of hyporeflective cavities in optical coherence tomography of patients with macular telangiectasia compared to patients with diabetic maculopathy. | Acta Ophthalmol | 2014 |
| 23099917 | Ranibizumab for the management of Sorsby fundus dystrophy. | Eye (Lond) | 2013 |
| 26734182 | Improving treatment provision of Wet AMD with intravitreal ranibizumab. | BMJ Qual Improv Rep | 2013 |
| 20075972 | Baseline clinical measures and early response predict success in verteporfin photodynamic therapy for neovascular age-related macular degeneration. | Eye (Lond) | 2010 |
| 18425070 | Early response of retinal angiomatous proliferation treated with intravitreal pegaptanib: a retrospective review. | Eye (Lond) | 2009 |
| 19074914 | Observational prospective study of the effectiveness in routine clinical practice of verteporfin photodynamic therapy in patients with neovascular age-related macular degeneration. | Br J Ophthalmol | 2009 |
| 17962391 | Displacement of nuclear fragments into the vitreous complicating phacoemulsification surgery in the UK: clinical features, outcomes and management. | Br J Ophthalmol | 2008 |
| 17965101 | Displacement of nuclear fragments into the vitreous complicating phacoemulsification surgery in the UK: incidence and risk factors. | Br J Ophthalmol | 2008 |
| 16424548 | Solar retinopathy in a patient with bipolar affective disorder. | Br J Ophthalmol | 2006 |
| 11318272 | Sphenoid sinus mucocoele mimicking aneurysmal oculomotor nerve palsy. | Eye (Lond) | 2001 |